Incompetent executive directors and leadership that breeds toxic people in FE&A - Avis employé Employé (anonyme) Merck

1,0
25 févr. 2024
Employé (anonyme)
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Ask me next time on pros

Inconvénients

Culture is not what it used to be. Used to have good leadership and directors. Low IQ leadership team, extreme gaslighting and divisive behavior by two of the executive directors, the woman is crazy, they like to blame you for their incompetence and lack of experience in this space. Like to talk badly behind your back.

Découvrez plus d’avis sur Merck

5,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Excellent company to work with.

Inconvénients

No cons encountered so far

4,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Inconvénients

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Voir les avis par: Utile|Évaluation|Date|Tout